In this fifth, and final, special bonus episode of our Pride Month series, we speak with Lauren Albrecht, director of advocacy and organizing, and Layla Orlando, director of health equity and wellness, at Garden State Equality, the largest lesbian, gay, bisexual, transgender, queer, plus advocacy organization in New Jersey.
Garden State Equality celebrates its 20th anniversary this year. Since its founding in 2004, it has grown to more than 150,000 members | Image Credit: Garden State Equality
Welcome to the final episode in our special Pride Month series. In this special edition of Managed Care Cast, we speak with Lauren Albrecht, director of advocacy and organizing, and Layla Orlando, director of health equity and wellness, at Garden State Equality, first founded in 2004 and which has grown to become the largest lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+) advocacy organization in New Jersey, at more than 150,000 members.
Racial, economic, and disability justice concerns underpin this advocacy and civil rights organization’s mission to bring full equality to all members of all LGBTQ+ communities in the state. We discuss state- and federal-level legislation, with potential implications on not only LGBTQ+ rights in the state, but reproductive freedom as well; notable achievements for the LGBTQ+ community in New Jersey; and, as with our previous episodes in this limited-edition series, health care policy in this election year.
Please check out our previous episodes with Lancaster Pride, Rutgers, Callen-Lorde, and We Are Family.
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More